Abstract
Testosterone and epitestosterone are mainly excreted as glucuronides. The aim of this study was to develop and validate a method using liquid chromatography tandem mass spectrometry (LC-MS/MS) to analyse testosterone and epitestosterone in rat serum and urine to assist in vivo studies on steroid metabolism. The method was developed by spiking charcoal stripped rat plasma and urine with the analytes. The developed method was then applied to serum (n=6) and urine samples (n=6) from young male brown Norway rats to determine testosterone and epitestosterone concentrations. The assay showed linearity within quantification range coefficient (r2) values above 0.991. Optimum conditions were determined for the deconjugation of glucuronidated testosterone and epitestosterone along with the internal standard stanozolol D3. Accuracy, precision and extraction recovery for both compounds was satisfactory in both matrices. The method was capable of quantifying 0.250 ng/mL concentrations of testosterone and epitestosterone in 100 μL of serum and urine. The average concentrations of free and deconjugated testosterone and epitestosterone found in the rat samples were: urine–201.68 ± 90.16 ng/mL and 85.37 ± 21.20 ng/mL; serum– 363.40 ± 11.615 ng/mL and 1.75 ± 0.118 ng/mL, respectively. This method is sensitive, specific and reproducible for the determination of free and deconjugated testosterone and epitestosterone in rat serum and urine. The method can be used for in vivo analysis for further investigations of testosterone and epitestosterone concentrations in studies monitoring endocrine dysfunctions and doping.
Highlights
The 2014 World Anti-Doping Agency (WADA) Prohibited List shows testosterone and epitestosterone listed as class S1.1a and S1.1b, with its use banned in and out of competition [1]
According to the 2012 (WADA) laboratory statistics, elevated testosterone based on the testosterone over epitestosterone (T/E) ratio accounts for 55.5% of atypical findings within the anabolic agents’ drug class from a total of 2,279 for all anabolic agents, which constitute half of all adverse and atypical findings [3]
This T/E ratio approach to testing for testosterone abuse is only accurate if testosterone and epitestosterone are metabolised at the same rate and no other external factors or inter individual factors would alter the metabolism of these steroids [4]
Summary
The 2014 World Anti-Doping Agency (WADA) Prohibited List shows testosterone and epitestosterone listed as class S1.1a and S1.1b, with its use banned in and out of competition [1]. According to the 2012 (WADA) laboratory statistics, elevated testosterone based on the testosterone over epitestosterone (T/E) ratio accounts for 55.5% of atypical findings within the anabolic agents’ drug class from a total of 2,279 for all anabolic agents, which constitute half of all adverse and atypical findings [3]. This T/E ratio approach to testing for testosterone abuse is only accurate if testosterone and epitestosterone are metabolised at the same rate and no other external factors or inter individual factors would alter the metabolism of these steroids [4]. Extending these potentially significant in vitro results to in vivo, experimentation calls for a streamlined analytical procedure that caters for analysing multiple biological samples, such as urine and blood without introducing intra-method variances owing to different sensitivity and specificity
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Journal of Analytical & Bioanalytical Techniques
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
